ICON Public Limited Company (ICLR)

268.65 +2.04 (+0.77%) As of 03:17PM EST. Market open.

ICON Public Limited Company

South County Business Park
Leopardstown
Dublin 18
Ireland
353 1 291 2000
https://www.iconplc.com

Sector(s): Healthcare
Industry: Diagnostics & Research
Full-time employees: 41,150

Key executives

Name	Title	Pay	Exercised	Year born
Dr. Steven A. Cutler MBA, Ph.D.	CEO & Director	2.54M	N/A	1960
Mr. Brendan Brennan	Chief Financial Officer	998k	N/A	1979
Jonathan Andrew Curtain	Senior Vice President of Corporate & Commercial Finance	N/A	N/A	1976
Mr. Thomas N. O'Leary	Chief Information Officer	N/A	N/A	N/A
Mr. Diarmaid Cunningham	Chief Administrative Officer, General Counsel & Company Secretary	N/A	N/A	1975
Ms. Niamh Murphy	Director of Corporate Communications	N/A	N/A	N/A
Mr. David Green	Vice President of Marketing	N/A	N/A	N/A
Mr. Joe Cronin	Chief Human Resources Officer	N/A	N/A	N/A
Mr. Simon Holmes	President of Corporate Investments & Partnerships	N/A	N/A	1967
Dr. Gary Curtis	Senior Vice President of Global Clinical Pharmacology	N/A	N/A	N/A

Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It offers clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; and clinical research services, including biostatistics, clinical operations, clinical supplies management, covid-19, data management, decentralized & hybrid clinical solutions, endpoint adjudication services, interactive response technologies, investigator payments, medical affairs, medical writing and publishing, pharmacovigilance, and site and patient solutions. The company also provides laboratory services, including bionanalytical, biomarker, vaccine, good manufacturing practice, and central laboratory services, as well as full-service and functional service partnerships to customers. In addition, it offers commercial positioning, early phase, language, medical imaging, and strategic solutions, as well as clinical trial management, consulting, and contract staffing services. The company serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. ICON Public Limited Company was incorporated in 1990 and is headquartered in Dublin, Ireland.

Corporate governance

ICON Public Limited Company’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.